655 related articles for article (PubMed ID: 5147595)
1. Drug product quality.
Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
[No Abstract] [Full Text] [Related]
2. Report on the PQRI impurity characterization and quantification best practices survey.
Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
[No Abstract] [Full Text] [Related]
3. USP general chapter <797> pharmaceutical compounding-sterile preparations.
Hung JC
J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
[No Abstract] [Full Text] [Related]
4. GMPs vs GCPs: manufacturing and compounding definitions.
Allen LV
Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
[No Abstract] [Full Text] [Related]
5. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
[No Abstract] [Full Text] [Related]
6. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
7. Influence of compounding on sterility and stability of drugs.
Hardee GE
J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
[No Abstract] [Full Text] [Related]
8. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
9. [Various aspects of the significance of government control in drug supply].
Teijgeler CA; Samsom RJ
Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999
[No Abstract] [Full Text] [Related]
10. WHO expert committee on specifications for pharmaceutical preparations. Twenty-fifth report.
World Health Organ Tech Rep Ser; 1975; (567):1-115. PubMed ID: 807046
[No Abstract] [Full Text] [Related]
11. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
[No Abstract] [Full Text] [Related]
12. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
[TBL] [Abstract][Full Text] [Related]
13. Quality assurance for medical products: unified program for all federal agencies.
Flaherty FJ
Hosp Formul; 1976 Dec; 11(12):669, 674, 679. PubMed ID: 1028796
[No Abstract] [Full Text] [Related]
14. The art, science, and practice of pharmacy compounding.
McDonough RP; Allen LV; Wettergreen S
J Am Pharm Assoc (2003); 2013; 53(1):8-12. PubMed ID: 23636149
[No Abstract] [Full Text] [Related]
15. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
Jimenez FA
Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
[No Abstract] [Full Text] [Related]
16. Assuring total drug quality.
Simmons HE
J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621
[No Abstract] [Full Text] [Related]
17. ASHP statement on hospital drug control systems.
Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
[No Abstract] [Full Text] [Related]
18. What is quality of medicines?
Doogue MP; Thynne TR
Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167
[No Abstract] [Full Text] [Related]
19. Introduction to Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
[TBL] [Abstract][Full Text] [Related]
20. Does your pharmacy have a compounding isolator?
LaBella CJ
Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
